ADKUDO Trademark

Trademark Overview

On Wednesday, August 25, 2021, a trademark application was filed for ADKUDO with the United States Patent and Trademark Office. The USPTO has given the ADKUDO trademark a serial number of 90901586. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, September 26, 2024. This trademark is owned by CORCEPT THERAPEUTICS INCORPORATED. The ADKUDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders; all of the foregoing excluding pharmaceutical preparations or therapeutic agents administered by infusion or for treating hematological diseases, hematological disorders, or blood cancers

General Information

Serial Number90901586
Word MarkADKUDO
Filing DateWednesday, August 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders; all of the foregoing excluding pharmaceutical preparations or therapeutic agents administered by infusion or for treating hematological diseases, hematological disorders, or blood cancers
Pseudo MarkAD KU DO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCORCEPT THERAPEUTICS INCORPORATED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065
Party NameCORCEPT THERAPEUTICS INCORPORATED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMENLO PARK, CA 94025

Trademark Events

Event DateEvent Description
Saturday, August 28, 2021NEW APPLICATION ENTERED
Tuesday, October 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 16, 2022ASSIGNED TO EXAMINER
Wednesday, March 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 5, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, October 27, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, November 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 4, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, November 21, 2022ASSIGNED TO PETITION STAFF
Tuesday, November 22, 2022POST PUBLICATION AMENDMENT - ENTERED
Tuesday, December 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 24, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 24, 2023SOU EXTENSION 1 FILED
Friday, March 24, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU EXTENSION 2 FILED
Thursday, November 30, 2023SOU EXTENSION 2 GRANTED
Friday, December 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024SOU EXTENSION 3 GRANTED
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024SOU EXTENSION 3 FILED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 26, 2024SOU EXTENSION 4 FILED
Friday, April 18, 2025SOU TEAS EXTENSION RECEIVED
Thursday, September 26, 2024SOU EXTENSION 4 GRANTED

Related Keywords

adkudo pharmaceutical disorders preparations diseases treatment hematological cushing cancers therapeutic excluding